Staphylococcal scalded skin syndrome: a rare complication of a common pathogen.
Ahuja
Mohit
M
University of Mississippi Medical Center, Jackson, MS, USA.
Hrom
John
J
Woods
Amy
A
Brown
Andy
A
Lopez
Fred A
FA
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000907:Antibodies, Bacterial / Q000097:blood; D001427:Bacterial Toxins / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D000077723:Cefepime; D002511:Cephalosporins / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004768:Enterotoxins / Q000276:immunology; D005260:Female; D006801:Humans; D016106:Methicillin Resistance; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage; D013206:Staphylococcal Scalded Skin Syndrome / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D013211:Staphylococcus aureus / Q000302:isolation & purification*; D018089:Superantigens / Q000276:immunology; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D001427:Bacterial Toxins; D015415:Biomarkers; D002511:Cephalosporins; D004768:Enterotoxins; D018089:Superantigens; C030107:enterotoxin F, Staphylococcal; C031818:enterotoxin B, staphylococcal; D014640:Vancomycin; D000077723:Cefepime; D012293:Rifampin